Economou M et al. reported the rates of impaired renal function with elevated cystatin C levels (36%), glomerular dysfunction with proteinuria (24%), and tubulopathy with hypercalciuria (35.5%), among children and adolescents with β-TM on iron chelation therapy [21]. Here, CST3 is linked to Hypercalciuria.